![Kennet Rooth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kennet Rooth
Président chez Rare Thyroid Therapeutics International AB
Postes actifs de Kennet Rooth
Sociétés | Poste | Début | Fin |
---|---|---|---|
Swedish Orphan Biovitrum International AB
![]() Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Sales & Marketing | 16/02/2010 | - |
Rare Thyroid Therapeutics International AB
![]() Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Président | - | - |
Historique de carrière de Kennet Rooth
Anciens postes connus de Kennet Rooth
Sociétés | Poste | Début | Fin |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | President | 23/02/2011 | 15/08/2011 |
Sales & Marketing | 28/07/2010 | 23/02/2011 | |
Swedish Orphan International Holding AB
![]() Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Sales & Marketing | 01/01/2005 | 03/06/2010 |
Formation de Kennet Rooth
INSEAD | Undergraduate Degree |
Statistiques
Internationale
Suède | 5 |
France | 2 |
Opérationnelle
Sales & Marketing | 3 |
Undergraduate Degree | 1 |
President | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Entreprise privées | 3 |
---|---|
Swedish Orphan International Holding AB
![]() Swedish Orphan International Holding AB Pharmaceuticals: MajorHealth Technology Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983. In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan. The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets. | Health Technology |
Swedish Orphan Biovitrum International AB
![]() Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Health Technology |
Rare Thyroid Therapeutics International AB
![]() Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Health Technology |
- Bourse
- Insiders
- Kennet Rooth
- Expérience